Christopher Simpson counsels clients regarding a wide range of transactional and corporate law matters. Mr. Simpson advises clients across the spectrum – from growth-oriented companies to private equity funds – on significant mergers, acquisitions, and similar transactions as well as day to day strategic and commercial matters.
Private Equity: represents and advises private equity funds in connection with initial investments, interim transactions and exit sales. Represents and advises portfolio companies on operational, strategic, and commercial matters.
Mergers & Acquisitions: Represents private equity sponsor-backed, as well as venture- and founder-backed companies in acquisitions, sales and recapitalizations.
Business & Technology: represents and advises public and private companies in a variety of industries in mergers and acquisitions, securities law compliance issues, venture capital equity financings and general corporate work.
Life Sciences: represents and advises life sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early-stage life science and emerging life sciences companies.
Professional and Community Involvement
Mr. Simpson is a member of the Leukemia and Lymphoma Society.
Education & Credentials
Notre Dame Law School
JD, magna cum laude, 2011
Notre Dame Law Review, Articles Editor